Back to Results
First PageMeta Content
Pharmaceuticals policy / Pharmaceutical industry / Pharmacy / GlaxoSmithKline / Generic drug / Pfizer / Food and Drug Administration / Intas Biopharmaceuticals / Pharmaceutical sciences / Pharmacology / Health


Document Date: 2012-05-31 05:34:33

Open Document

File Size: 4,67 MB

Share Result on Facebook

City

Oslo / Marocco / Kalundborg / /

Company

Takeda Pharmaceutical / Herkules Private Equity Fund / Par Pharmaceutical Inc. / Oslo Stock Exchange / COMMERCIAL PARTNERS / Teva Pharmaceuticals USA Inc. / Pronova BioPharma Group / Sandoz Inc. / Apotex Inc. / Pronova BioPharma ASA / GlaxoSmithKline / Endo Pharmaceuticals / Apotex Corp. / Pfizer Italia / Abbott Laboratories / Par Pharmaceutical Companies Inc. / /

Continent

Asia / Europe / /

Country

Taiwan / Germany / Venezuela / Netherlands / Italy / Macedonia / South Africa / Egypt / Norway / Belgium / France / Malaysia / Japan / Russia / United States / Brazil / Vietnam / Canada / Australia / Portugal / Korea / United Kingdom / China / Argentina / Spain / Greece / India / Ireland / Denmark / /

Currency

USD / /

Event

Legal Issues / FDA Phase / Business Partnership / /

Facility

Group’s plant / NEW LIPID DRUG PIPELINE / United States District Court / /

Holiday

Commonwealth Day / /

IndustryTerm

pharmaceutical drug / pharmaceutical drug candidates / supply chain / pharmaceutical product / proposed generic drug products / pharmaceutical / consumer healthcare space / prevention of cardiovascular disease / commercialised pharmaceutical product / treatment of cardiovascular / metabolic and inflammatory diseases / blockbuster product / efficacious products / pharmaceutical market / consumer healthcare / health bringing products / pharmaceutical products / generic products / life-cycle management / manufacturing advantage / manufacturing yield increase / /

MedicalCondition

metabolic and inflammatory diseases / cardiovascular diseases / cardiovascular disease / heart attack / post-myocardial infarction / /

MusicAlbum

Central / South America / /

Organization

German Federal Patent Court / Commonwealth of Independent States / United States District Court for the District of Delaware / DHA / US Food and Drug Administration / American Heart Association / Environmental Protection Agency / /

Person

Pierre Fabre / Pierre Fabre Médicament / /

Position

honesty and innovation PIONEER AND LEADER / player / head / Major / important player in the non-statin cardiovascular segment / /

Product

Omacor / Lovaza / HEART PATIENTS CAPSULES / prescription drug / USA / Lovaza™ / Q3 / /

ProvinceOrState

Delaware / /

Region

Middle East / North Africa / Central America / East Asia / South America / SouthEast Asia / South Korea / Eastern Europe / Central Africa / /

SocialTag